ArticleAdvances in therapy2026

Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS Study.

Karen Gambaro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.